PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Hypotension 42,123 Disease Target 11-Beta-Hydroxylase 721 4 0.00 -1.00 0.01 0.56
Collagen 138,882 Target Target 11-Beta-Hydroxylase 721 2 0.00 -1.00 0.00 0.52
Seizure 44,685 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.53
Hypoglycemia 20,698 Disease Target 11-Beta-Hydroxylase 721 2 0.00 -1.00 0.00 0.56
Hyperbilirubinemia 5,757 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.58
Meningitis 41,685 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.53
Diabetes 332,602 Disease Target 11-Beta-Hydroxylase 721 4 0.00 -1.00 0.01 0.51
Endometriosis 16,342 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.55
Platelet Aggregation 25,460 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.54
Carcinoma 433,099 Disease Target 11-Beta-Hydroxylase 721 19 0.00 -0.99 0.03 0.54
Hemorrhage 100,979 Disease Target 11-Beta-Hydroxylase 721 4 0.00 -1.00 0.01 0.54
APOE 12,771 Target Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.56
Lanosterol 14 Alpha-Demethylase 101 Target Target 11-Beta-Hydroxylase 721 1 0.00 -0.99 0.01 0.68
Prostate Cancer 71,064 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.51
Depression 220,092 Disease Target 11-Beta-Hydroxylase 721 8 0.00 -0.99 0.01 0.54
Steroid 5-Alpha-Reductase 293 Target Target 11-Beta-Hydroxylase 721 4 0.01 -0.99 0.01 0.71
Dyslipidemia 15,225 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.55
Cancer 1,053,491 Disease Target 11-Beta-Hydroxylase 721 10 0.00 -0.99 0.01 0.51
Dehydration 21,928 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.54
Shock 134,031 Disease Target 11-Beta-Hydroxylase 721 3 0.00 -1.00 0.00 0.53
Major Depressive Disorder 12,517 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.56
Renin 43,456 Target Target 11-Beta-Hydroxylase 721 55 0.01 -0.96 0.08 0.64
Gynecomastia 2,594 Disease Target 11-Beta-Hydroxylase 721 7 0.01 -0.99 0.01 0.67
Obesity 138,233 Disease Target 11-Beta-Hydroxylase 721 2 0.00 -1.00 0.00 0.52
EGF 27,487 Target Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.54
Acne 11,364 Disease Target 11-Beta-Hydroxylase 721 5 0.00 -1.00 0.01 0.61
Infection 766,637 Disease Target 11-Beta-Hydroxylase 721 2 0.00 -1.00 0.00 0.48
Platelet Activating Factor 9,915 Target Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.56
Stroke 146,992 Disease Target 11-Beta-Hydroxylase 721 6 0.00 -1.00 0.01 0.54
Anxiety 113,510 Disease Target 11-Beta-Hydroxylase 721 3 0.00 -1.00 0.00 0.53
Calmodulin 25,240 Target Target 11-Beta-Hydroxylase 721 3 0.00 -1.00 0.00 0.57
Arrhythmia 29,330 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.54
Hyperprolactinemia 4,112 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.59
Diarrhea 51,986 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.52
Epilepsy 71,172 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.51
Renal Failure 73,993 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.51
Brain Injury 34,874 Disease Target 11-Beta-Hydroxylase 721 2 0.00 -1.00 0.00 0.55
Pain 409,851 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.48
Angiotensin Converting Enzyme 31,674 Target Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.53
Glucocorticoid Receptor 10,306 Target Target 11-Beta-Hydroxylase 721 7 0.00 -0.99 0.01 0.62
Cholesterol 182,390 Disease Target 11-Beta-Hydroxylase 721 98 0.01 -0.93 0.14 0.61
Sepsis 64,798 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.52
Sedation 27,984 Disease Target 11-Beta-Hydroxylase 721 3 0.00 -1.00 0.00 0.56
CD4 112,219 Target Target 3-Phosphoinositide-Dependent Protein Kinase 1 230 1 0.00 -1.00 0.00 0.53
Non Small Cell Lung Cancer 28,563 Disease Target 3-Phosphoinositide-Dependent Protein Kinase 1 230 2 0.00 -1.00 0.01 0.58
Lung Cancer 91,416 Disease Target 3-Phosphoinositide-Dependent Protein Kinase 1 230 4 0.00 -0.99 0.02 0.56
Epidermal Growth Factor Receptor 24,772 Target Target 3-Phosphoinositide-Dependent Protein Kinase 1 230 3 0.00 -0.99 0.01 0.59
Diabetes 332,602 Disease Target 3-Phosphoinositide-Dependent Protein Kinase 1 230 9 0.00 -0.98 0.04 0.55
Colon Cancer 30,064 Disease Target 3-Phosphoinositide-Dependent Protein Kinase 1 230 2 0.00 -1.00 0.01 0.57
Colon Cancer 30,064 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.57
Graft Versus Host Disease 15,741 Disease Target 4-1BB Ligand 135 2 0.00 -0.99 0.01 0.60
Obesity 138,233 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.53
Infection 766,637 Disease Target 4-1BB Ligand 135 11 0.00 -0.96 0.08 0.55
CEA 17,022 Target Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.58
Diabetes 332,602 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.52
4-1BB Receptor 20 Target Target 4-1BB Ligand 135 9 0.17 -0.72 0.45 0.85
CD14 9,941 Target Target 4-1BB Ligand 135 3 0.00 -0.99 0.02 0.63
Cancer 1,053,491 Disease Target 4-1BB Ligand 135 27 0.00 -0.89 0.20 0.56
Conjunctivitis 8,825 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.60
CD4 112,219 Target Target 4-1BB Ligand 135 36 0.01 -0.86 0.27 0.63
Carcinoma 433,099 Disease Target 4-1BB Ligand 135 14 0.00 -0.95 0.10 0.57
BAFF 1,240 Target Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.65
CD1A 2,739 Target Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.63
Cervical Cancer 28,286 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.57
Cancer 1,053,491 Disease Target 4-1BB Receptor 20 5 0.00 -0.87 0.25 0.56
Graft Versus Host Disease 15,741 Disease Target 4-1BB Receptor 20 2 0.00 -0.95 0.10 0.63
Carcinoma 433,099 Disease Target 4-1BB Receptor 20 3 0.00 -0.92 0.15 0.56
CD4 112,219 Target Target 4-1BB Receptor 20 9 0.01 -0.74 0.45 0.62
Carcinoma 433,099 Disease Drug 4-Mercaptobenzoic Acid 70 1 0.00 -0.99 0.01 0.52
Dehydration 21,928 Disease Drug 4-Mercaptobenzoic Acid 70 1 0.00 -0.99 0.01 0.59
Cancer 1,053,491 Disease Drug 4-Mercaptobenzoic Acid 70 4 0.00 -0.97 0.06 0.53
Hepatitis B 57,815 Disease Drug 4-Mercaptobenzoic Acid 70 2 0.00 -0.99 0.03 0.58
4-Mercaptopyridine 96 Drug Drug 4-Mercaptobenzoic Acid 70 2 0.02 -0.98 0.03 0.79
Renal Failure 73,993 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.58
Eotaxin 2,457 Target Target 464.1 19 1 0.00 -0.97 0.05 0.66
Carcinoma 433,099 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.54
Acute Promyelocytic Leukemia 4,780 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.65
Prostate Cancer 71,064 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.58
Cancer 1,053,491 Disease Target 464.1 19 2 0.00 -0.95 0.11 0.54
Diabetes 332,602 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.55
744.1 22 Target Target 464.1 19 1 0.05 -0.95 0.05 0.83
ERK1 18,374 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.59
Rheumatoid Arthritis 78,952 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.56
Anxiety 113,510 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.55
Analgesia 44,857 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.57
Phospholipase A2 13,400 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.60
Obsessive Compulsive Disorder 8,508 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.61
Insomnia 12,434 Disease Target 5-Hydroxytryptamine 2a Receptor 67 3 0.00 -0.98 0.04 0.63
Seizure 44,685 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.57
Schizophrenia 77,034 Disease Target 5-Hydroxytryptamine 2a Receptor 67 10 0.00 -0.92 0.15 0.61
Calmodulin 25,240 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.58
Infection 766,637 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.51
Hyperglycemia 28,168 Disease Target 5-Hydroxytryptamine 2a Receptor 67 2 0.00 -0.98 0.03 0.60
Diabetes 332,602 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.53
Attention Deficit Hyperactivity Disorder 14,687 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.60
Depression 220,092 Disease Target 5-Hydroxytryptamine 2a Receptor 67 5 0.00 -0.96 0.07 0.57
Obesity 138,233 Disease Target 5-Hydroxytryptamine 2a Receptor 67 2 0.00 -0.98 0.03 0.56
Catechol O-Methyltransferase 2,877 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.64
Epidermal Growth Factor Receptor 24,772 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.58
5-Hydroxytryptamine 2b Receptor 18 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.03 -0.96 0.06 0.79